⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 17, 2024

Figure S7 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma

Sofia Geroyska Isabel Mejia Alfred A. Chan Marian S. Navarrete Vijaya Pandey Samuel Kharpatin Juliana Noguti Feng Wang Daniel Srole Tsui‐Fen Chou James A. Wohlschlegel Elizabeta Nemeth Robert Damoiseaux David B. Shackelford Delphine J. Lee Begoña Díaz

View Full Paper

Ask AI

Bookmark

Share

Abstract

Treatment with necroptosis and pyroptosis inhibitors fail to prevent cell death induced by of NMTi treatment in lung carcinoma cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Geroyska et al. (2024) studied this question.

synapsesocial.com/papers/68e5833db6db643587520e5a https://doi.org/10.1158/2767-9764.27045871

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S6 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
2Figure S8 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
3Figure S10 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
4Figure S1 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024
5Figure S11 from N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma2024